BATS BZX Real-Time Price
As of 3:10pm ET
| -0.325 / -0.89%|
The 8 analysts offering 12-month price forecasts for Royalty Pharma PLC have a median target of 52.50, with a high estimate of 60.00 and a low estimate of 47.00. The median estimate represents a +44.91% increase from the last price of 36.23.
The current consensus among 8 polled investment analysts is to Buy stock in Royalty Pharma PLC. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.